Form 4: Rockwell Medical COO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Rockwell Medical's Chief Operating Officer, Heather Hunter, sold 2,868 shares of common stock at $0.8355 per share on January 2, 2026, under a pre-arranged 10b5-1 trading plan.
Summary
- Heather Hunter, Chief Operating Officer of Rockwell Medical, Inc. (RMTI), reported a sale of common stock.
- The transaction involved the disposition of 2,868 shares of common stock.
- The shares were sold at a price of $0.8355 per share.
- The transaction date was January 2, 2026.
- Following this transaction, Heather Hunter beneficially owns 132,523 shares of common stock directly.
- The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by the Reporting Person on December 13, 2024.
Sentiment
Score: 5
Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan, which is generally considered neutral as it does not typically indicate new discretionary sentiment from the insider.
Future Outlook
This filing does not contain any forward-looking statements or guidance.
Industry Context
This insider transaction is a routine disclosure required by the SEC for officers of publicly traded companies. Sales under Rule 10b5-1 plans are pre-scheduled and generally do not reflect new discretionary trading decisions based on recent material non-public information.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan Adoption | The Chief Operating Officer adopted a Rule 10b5-1 trading plan on December 13, 2024, under which the reported stock sale was executed. | 2024-12-13 | The adoption of a 10b5-1 plan provides an affirmative defense against insider trading allegations for pre-scheduled trades, enhancing transparency and compliance with insider trading regulations. |
Stakeholder Impact
- Shareholders: The sale represents a minor dilution of insider ownership, but given it's a pre-arranged 10b5-1 plan and a small number of shares, the impact on shareholder sentiment is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 2024-12-13 | Date Reporting Person adopted the Rule 10b5-1 trading plan. |
| 2026-01-02 | Date of the reported transaction (sale of common stock). |
| 2026-01-05 | Date the Form 4 was signed and filed. |
Keywords
RMTI, Rockwell Medical, Form 4, Insider Trading, Stock Sale, Heather Hunter, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.